Block the great escape

Xomics is a preclinical-stage  biotech  start-up inventing novel broad-spectrum biologics for overcoming tumor escape - a critical challenge in fighting cancer.

Cancer Cell Plasticity is a fundamental non-genetic mechanism leading to tumor recurrence and deadly metastasis. Through changing their "identities",  a small number of highly plastic cancer cells can escape immune attack, survive current therapy, and spread in the body. 

Xomics is developing  first-in-class biologics to selectively attack those persistent malignant cells throughout their escaping journey, opening new possibilities for treating many types of aggressive tumors.

Please contact us for more information.

1400 Bridge Pkwy, Suite 202, Redwood City, CA 94065